Cost-Effectiveness of Prophylactic Medications for the Treatment of Hereditary Angioedema Due to C1 Inhibitor Deficiency: A Real-World U.S. Perspective
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.